Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Autolus Therapeutics plc - American Depositary Shares (NQ:AUTL)

1.505 -0.095 (-5.94%)
Streaming Delayed Price Updated: 11:01 AM EDT, Apr 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Autolus Therapeutics plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 Next >
Autolus Announces Pricing of Public Offering
From Autolus Therapeutics plc
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Autolus Announces Proposed Public Offering in the United States
From Autolus Therapeutics plc
Via GlobeNewswire
Autolus Therapeutics: Q3 Earnings Insights
Autolus Therapeutics (NASDAQ:AUTL) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Moderna In-Licenses Autolus' Technology For mRNA-Based Cancer Therapeutics
Via Benzinga
Recap: Autolus Therapeutics Q2 Earnings
  Autolus Therapeutics (NASDAQ:AUTL) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Autolus Therapeutics to Receive $70 Million in Milestone Payments from Blackstone Life Sciences
From Autolus Therapeutics plc
Via GlobeNewswire
Autolus Therapeutics announces pivotal Phase 2 FELIX clinical trial has met primary endpoint at interim analysis
From Autolus Therapeutics plc
Via GlobeNewswire
Autolus Therapeutics announces handover of first clean rooms of new Stevenage, UK, manufacturing facility
From Autolus Therapeutics plc
Via GlobeNewswire
Earnings Scheduled For March 10, 2022
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Autolus Therapeutics to Present Three Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2022
From Autolus Therapeutics plc
Via GlobeNewswire
Autolus Therapeutics Reports Third Quarter 2022 Financial Results and Operational Progress
From Autolus Therapeutics plc
Via GlobeNewswire
Autolus Therapeutics to Report Third Quarter 2022 Financial Results on November 3, 2022
From Autolus Therapeutics plc
Via GlobeNewswire
Moderna exercises option to license proprietary targeting technology from Autolus
From Autolus Therapeutics plc
Via GlobeNewswire
R&D Efforts to Improve Optimal Treatments for Advanced Pancreatic Ductal Adenocarcinoma (PDAC) Progressing
Palm Beach, FL – October 5, 2022 – FinancialNewsMedia.com News Commentary – Advanced pancreatic ductal adenocarcinoma (PDAC) remains a significant cause of mortality accounting for up to 4% of all... 
Via FinancialNewsMedia
Topics Death
Exposures Death
11 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Bionano Genomics (NASDAQ:BNGO) stock increased by 9.8% to $2.24. The company's market cap stands at $649.9 million. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for another overview of the biggest pre-market stock movers for Wednesday as we cover the news behind share movement this morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers 
Via Benzinga
Autolus Therapeutics Stock Jumps After Bristol Myers Pact For Safety Switch System
Via Benzinga
Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session
Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday. 
Via Benzinga
Autolus Therapeutics Announces Collaboration with Bristol Myers Squibb for Use of Autolus’ Proprietary Safety Switch System
From Autolus Therapeutics plc
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Scopus BioPharma (NASDAQ:SCPS) stock moved upwards by 10.9% to $0.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $6.3 million. 
Via Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Recap: Autolus Therapeutics Q4 Earnings
Autolus Therapeutics (NASDAQ:AUTL) reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
40 Stocks Moving In Monday's Mid-Day Session
Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction.... 
Via Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (... 
Via Benzinga
Why Autolus Therapeutics Stock Jumped 25% Today
A private equity firm is taking a $100 million stake in the biotech. 
Via The Motley Fool
58 Biggest Movers From Yesterday
Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-... 
Via Benzinga
64 Biggest Movers From Yesterday
Gainers Pioneer Power Solutions, Inc. (NASDAQ: PPSI) shares jumped 219% to close at $10.40 on Monday after the company announced the launch of its E-Boost portfolio of mobile... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.